Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors.
Pietroluongo E, De Placido P, Tortora M, Martinelli C, Viggiano A, Saponaro MR, Caltavituro A, Buonaiuto R, Morra R, Ottaviano M, Del Deo V, Cernera G, Gelzo M, Malfitano AM, Di Tolla MF, De Angelis C, Arpino G, Terracciano D, Bianco R, Veneziani BM, Formisano P, Castaldo G, Palmieri G, De Placido S, Giuliano M. Pietroluongo E, et al. Among authors: castaldo g. J Thorac Oncol. 2023 Oct;18(10):1399-1407. doi: 10.1016/j.jtho.2023.06.015. Epub 2023 Jun 28. J Thorac Oncol. 2023. PMID: 37390981 Free PMC article.
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response.
Cernera G, Gelzo M, De Placido P, Ottaviano M, Pietroluongo E, Raia M, Scalia G, Tortora M, Castaldo G, Formisano P, Palmieri G, Giuliano M. Cernera G, et al. Among authors: castaldo g. Front Immunol. 2023 Aug 29;14:1233056. doi: 10.3389/fimmu.2023.1233056. eCollection 2023. Front Immunol. 2023. PMID: 37705978 Free PMC article.
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis.
Monteiro I, Nicolella V, Fiorenza M, Novarella F, Carotenuto A, Lanzillo R, Mauriello L, Scalia G, Castaldo G, Terracciano D, Brescia Morra V, Moccia M. Monteiro I, et al. Among authors: castaldo g. J Neurol. 2024 Aug;271(8):5012-5024. doi: 10.1007/s00415-024-12434-w. Epub 2024 May 23. J Neurol. 2024. PMID: 38777960 Free PMC article.
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study.
Pietroluongo E, Peddio A, De Placido P, Tortora M, Ottaviano M, Gelzo M, Cernera G, Foggia M, Buonomo AR, Pinchera B, Zappulo E, Mercinelli S, Cattaneo L, Sardanelli A, Viceconte G, Scotto R, Schiano Moriello N, Servetto A, De Angelis C, Arpino G, Palmieri G, De Placido S, Bianco R, Castaldo G, Gentile I, Giuliano M. Pietroluongo E, et al. Among authors: castaldo g. BMC Cancer. 2024 Jun 19;24(1):748. doi: 10.1186/s12885-024-12405-4. BMC Cancer. 2024. PMID: 38898390 Free PMC article.
Immune Profile in COVID-19: Unveiling TR3-56 Cells in SARS-CoV-2 Infection.
Carriero F, Rubino V, Gelzo M, Scalia G, Raia M, Ciccozzi M, Gentile I, Pinchera B, Castaldo G, Ruggiero G, Terrazzano G. Carriero F, et al. Among authors: castaldo g. Int J Mol Sci. 2024 Sep 28;25(19):10465. doi: 10.3390/ijms251910465. Int J Mol Sci. 2024. PMID: 39408792 Free PMC article.
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.
Feola S, Chiaro J, Fusciello M, Russo S, Kleino I, Ylösmäki L, Kekäläinen E, Hästbacka J, Pekkarinen PT, Ylösmäki E, Capone S, Folgori A, Raggioli A, Boni C, Tiezzi C, Vecchi A, Gelzo M, Kared H, Nardin A, Fehlings M, Barban V, Ahokas P, Viitala T, Castaldo G, Pastore L, Porter P, Pesonen S, Cerullo V. Feola S, et al. Among authors: castaldo g. Int J Biol Macromol. 2024 Mar;262(Pt 1):129926. doi: 10.1016/j.ijbiomac.2024.129926. Epub 2024 Feb 6. Int J Biol Macromol. 2024. PMID: 38331062
306 results